AD 6, a coronary dilating agent, stimulates PGI2 production in rat aorta ex vivo and in human endothelial cells in culture
- 1 September 1982
- journal article
- research article
- Published by Elsevier in Pharmacological Research Communications
- Vol. 14 (8), 719-724
- https://doi.org/10.1016/s0031-6989(82)80077-5
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition.JCI Insight, 1981
- Prostaglandins in myocardial infarction: With emphasis on myocardial preservationProstaglandins and Medicine, 1981
- Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmiasNature, 1981
- Release of Prostaglandins and Thromboxane into the Coronary Circulation in Patients with Ischemic Heart DiseaseNew England Journal of Medicine, 1981
- Nitroglycerin Stimulates Synthesis of Prostacyclin by Cultured Human Endothelial CellsJCI Insight, 1981
- Effects of 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxy carboxyl methoxy coumarin (AD6) on aggregation, arachidonic acid metabolism and thromboxane B2 formation in human plateletsPharmacological Research Communications, 1980
- Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel WallsNew England Journal of Medicine, 1979
- Use of a radioimmunoassay to study thrombin-induced release of PGI2 from cultured endotheliumThrombosis Research, 1979
- Effects of 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonylmethoxy coumarin (AD6) on the coronary circulation in the dogPharmacological Research Communications, 1978
- HUMAN VASCULAR ENDOTHELIAL CELLS IN CULTUREThe Journal of cell biology, 1974